Merck & Co. 11 mai 2026 Merck makes a new move in Astra battle | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
Merck & Co. 11 mai 2026 Amid M&A buzz, Inhibrx's OX40-Keytruda combo shows promise in early look at midphase data - Fierce Biotech
PLoS Biology 11 mai 2026 The problem with one-size-fits-all medicine: Biological sex and the aging immune system
PLoS Biology 11 mai 2026 USP39 promotes antiviral defense through post-transcriptional control of RIG-I and stabilization of STING
BioPharma Dive 11 mai 2026 Inhibrx delivers ‘differentiated’ cancer drug data; Fractyl starts diabetes gene therapy trial
Charles River 11 mai 2026 Charles River Laboratories Introduces AI-Powered, End-to-End Workflow - Contract Pharma
FierceBiotech 11 mai 2026 Novo salvages happy ending for scrapped Parkinson’s cell therapy via deal with AI biotech
GE HealthCare 11 mai 2026 GE HealthCare next-gen SIGNA MR technology helps advance research discovery and translate innovation into clinical impact - Business Wire